CClinicalTrials.gg
Status unknownNCT05319704Speed-EnsoUpdated Apr 8, 2022

Specificities of the Eccentric Exercise: Energy Expenditure and Nature of Oxidized Substrates

An interventional study of Test of effort on cycle on concentric or excentric mode and Kinetics on concentric or excentric mode during test of effort in Overweight, Healthy and Men, sponsored by University Hospital, Clermont-Ferrand. Status unknown at 1 site in France. Open to male participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-08.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Feb 2021, registered Jun 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Male
01

Study summary

Main objective of this clinical trial is to compare the oxidation rates of main carbohydrate and lipid substrates during exercises carried out in eccentric dynamic pedaling mode on a cycloergometer compared to concentric exercises (classic pedaling) at the same oxygen consumption (VO2).

The hypothesis is that lipid oxidation during an eccentric exercise is higher than lipid oxidation during a concentric exercise, done in humans at the capacity of 30% of VO2max.

Read the detailed description

The written agreement of the subjects will be obtained after information on the aims, nature and possible risks of the study.

Before inclusion, the volunteers will be subjected to a medical check-up at the Nutritional Exploration Unit which includes an examination of personal and family history and current drug treatments, as well as a standard medical examination and a blood test for a biological check-up. Also, the volunteers will be subjected to a check-up with dietetics. Compliance with the inclusion/ exclusion criteria will be verified during this review. Volunteers included in the protocol will go to the Sports Medicine service, or the Nutritional Exploration Unit, or the Clinical Pharmacology Center (CPC) to perform the 11 interventions.

The study will be conducted in 6 periods:

T0 : A standard maximal exercices test performed on an cycloergometer to determine the subject's abilities (VO2) and to set the target powers of the experimental clinical tests. This test will take place in the Sports Medicine service.

T1 : A period of habituation to eccentric exercise, starting from 6 sessions of habituation realized over a period of 15 days where the sessions are gradually increased in duration and intensity. This test will take place in the Sports Medicine service. Before each session of habituation, a Visual Analogue Scale (VAS) will be performed. If the result will be greater than or equal to 3, the session will be rescheduled for another session after 48 hours.

T2 \& 3 : Two tests of effort, sub-maximal, progressive, carried out in eccentric mode and concentric mode (each spaced at least 48 hours) to determine the carbohydrate and lipid oxidation rates. Both tests will take place in the Sports Medicine service. The day before each visit, the evening meal will be standardized and eaten before 8 pm. Moreover, the day of both visits, the breakfast will be standardized and eaten 2 hours before the subject will go to Nutritional Exploration Unit.

T4 \& 5 : Two exercises tests during 30min performed at 30% VO2max and followed by indirect oxygen calorimetry (with canopy) extended over a period of 6 hours to measure the energy expenditure, the nature of the oxidized substrates (carbohydrates and lipids) and oxidation rates. The day before each visit, the evening meal will be standardized and eaten before 8 pm. Moreover, the day of both visits, the breakfast will be standardized and eaten 2 hours before the subject will go to Nutritional Exploration Unit. In addition, for each kinetic, 7 blood samples will be collected at several times. On these samples, insulin and blood sugar will be measured.

02

Conditions studied

  • Overweight
  • Healthy
  • Men

Browse trials for

Keywords

  • Energy expenditure
  • eccentric training
  • concentric training
  • oxidized substrates
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's planned enrollment of 12 is below the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male volunteers between 20 and 40 years old (20 ≥ years ≤ 40)
  • Subjects considered healthy by investigator based on the examination, medical and clinical examination
  • Body Mass Index between 27 and 35 kg/m² (27 \< BMI \< 35)
  • Biological check up considered compatible with study participation
  • Physical check up considered compatible with study participation (no bones, articular or muscular problems)
  • Person who don't smoke and has no treatment
  • Person who is in the position to sign informed consent

Exclusion criteria

Exclusion Criteria:

  • Smoking
  • Person who take any kind of treatments except Paracétamol
  • All conditions who have interaction with this clinical trial, or who can deteriorate the exercise capacity or the realization of canopy (claustrophobia)
  • Criteria
  • Administrative and legal factors
  • Person who isn't consent
  • Subject not affiliated with social security
  • Subject during the exclusion period of a previous study (after verification in the Biomedical Research Volunteers File).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Active comparator
    Test of effort, sub-maximal, progressive, carried out in eccentric mode

    The exercise will start at 10% of VO2max. However, every six minutes, the level of VO2max will be increased by 10%, up to 50%.

    Other: Test of effort on cycle on concentric or excentric mode · Other: Kinetics on concentric or excentric mode during test of effort

  • Placebo comparator
    Test of effort, sub-maximal, progressive, carried out in concentric mode

    The exercise will start at 10% of VO2max. However, every six minutes, the level of VO2max will be increased by 10%, up to 50%.

    Other: Test of effort on cycle on concentric or excentric mode · Other: Kinetics on concentric or excentric mode during test of effort

  • Active comparator
    Kinetic in eccentric mode

    The subjects will have to carry out a test of effort in eccentric or concentric mode during 30 minutes performed at 30% of VO2max. The exercise will be followed by indirect oxygen calorimetry (with canopy) extended over a period of 6 hours to measure the energy expenditure, the nature of the oxidized substrates (carbohydrates and lipids) and oxidation rates. During each kinetic, 6 other blood samples will be collected at several times. On these samples, insulin and blood sugar will be measured.

    Other: Test of effort on cycle on concentric or excentric mode · Other: Kinetics on concentric or excentric mode during test of effort

  • Placebo comparator
    Kinetic in concentric mode

    The subjects will have to carry out a test of effort in eccentric or concentric mode during 30 minutes performed at 30% of VO2max. The exercise will be followed by indirect oxygen calorimetry (with canopy) extended over a period of 6 hours to measure the energy expenditure, the nature of the oxidized substrates (carbohydrates and lipids) and oxidation rates. During each kinetic, 6 other blood samples will be collected at several times. On these samples, insulin and blood sugar will be measured.

    Other: Test of effort on cycle on concentric or excentric mode · Other: Kinetics on concentric or excentric mode during test of effort

Interventions

  • OtherTest of effort on cycle on concentric or excentric mode

    participants may receive 4 interventions sequentially during the protocol

  • OtherKinetics on concentric or excentric mode during test of effort

    participants may receive 4 interventions sequentially during the protocol

06

What researchers measure

Primary outcomes

  1. Measures of oxidation rate of lipid substrates at T2 visit and T3 visit

    The oxidation rate of lipid substrates is measured at 10% of VO2max, 20% of VO2max, 40% of VO2max and 50% of VO2max

    Time frame: Through effort test

Secondary outcomes

  1. Measures of oxidation rate of carbohydrates at T2 visit and T3 visit

    The oxidation rate of carbohydrates is measured at10% of VO2max, 20% of VO2max, 40% of VO2max and 50% of VO2max

    Time frame: Through effort test

  2. Measure of total energy expenditure at T2 visit and T3 visit

    At the T2 visit and T3 visit, the total energy expenditure is measured

    Time frame: Trough exercise

  3. Measure of total energy expenditure at T2 visit and T3 visit

    At the T2 visit and T3 visit, the total energy expenditure is measured

    Time frame: immediatly after exercise

  4. Measure of total energy expenditure at T2 visit and T3 visit

    At the T2 visit and T3 visit, the total energy expenditure is measured

    Time frame: through recovery after exercise, an average of 1 hour

  5. Measure of total energy expenditure

    the total energy expenditure is measured during constant-power cycle ergometer tests. This secondary outcome measure will be measured during eccentric and concentric exercises.

    Time frame: 30 min

  6. Measure of energy expenditure during 6 hours of recovery after exercises

    the energy expenditure is measured during constant-power cycle ergometer tests. This secondary outcome measure will be measured during both kinetics

    Time frame: 6 hours

  7. Measures of substrates oxidation rates at T4 visit and T5 visit

    The oxidation rates of substrates are measured during exercises performed at 30% of VO2max

    Time frame: through effort test

  8. Measures of quantities of oxidized substrates at T4 visit and T5 visit

    The quantities of oxidized substrates (carbohydrates, fats, proteins) are measured during exercises

    Time frame: through effort test

  9. Measures of quantities of carbohydrates at T4 visit and T5 visit

    The quantities of oxidized carbohydrates are measured during the measure of energy expenditure

    Time frame: Through energy expenditure measurment an average of 6 hours

  10. Measures of quantities of fats at T4 visit and T5 visit

    The quantities of fats are measured during the measure of energy expenditure

    Time frame: Through energy expenditure measurment an average of 6 hours

07

Study locations

1 of 1 sites recruiting
  • CHU clermont-ferrand
    Clermont-Ferrand, France
    • Lise Laclautre · Contact
    • Fabrice RANNOU · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05319704
Lead sponsor
University Hospital, Clermont-Ferrand
Responsible party
Sponsor
First posted
Apr 8, 2022
Start date
Feb 17, 2021
Primary completion
Aug 2023 (estimated)
Completion
Aug 2023 (estimated)
Last update
Apr 8, 2022

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
334.73.754.963
Fabrice RANNOU
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion